Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Tumor Biology

Abstract #3069: Progestin-dependent conversion of ER+PR+ CK5- luminal to ER\#8722;PR\#8722;CK5+ basal-like breast cancer stem cells

James Haughian, Carol Sartorius and Kathryn Horwitz
James Haughian
Univ. of Colorado-Denver, Anschutz Medical Campus, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol Sartorius
Univ. of Colorado-Denver, Anschutz Medical Campus, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Horwitz
Univ. of Colorado-Denver, Anschutz Medical Campus, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

Addition of progestins (P) to estrogens (E) for hormone replacement therapy (HRT) appears to increase the risk of developing breast cancer. The mechanisms remain unexplained. We recently demonstrated in solid tumor models of luminal cytokeratin 18 (CK18+)-positive, estrogen (ER+) and progesterone (PR+) receptor-positive breast cancer, that P expands a rare subpopulation of cells that are ER\#8722;PR\#8722; and express the basal, and stem cell marker, CK5. The ER-PR-CK5+ cells are CD44+, contain the multidrug resistance protein BCRP1, and exhibit tumorigenic properties of cancer stem cells (Horwitz et al. 2008 PNAS 105:5774). We speculated that P in HRT expands breast cancer stem cells in women with occult microdisease. Objective: To define mechanisms by which P expands ER\#8722;PR\#8722;CK5+ tumor-initiating, basal-like cells in ER+PR+CK5- luminal breast cancer. Results: ER+PR+ (T47D, MCF7, BT474), and ER+PR- (T47D-Y) luminal breast cancer cells are all CK5\#8722; in vitro. P treatment for 24h induces CK5 in 5-15% of the PR+ cells but not in the PR- cells. Antiprogestins block the P-dependent increase in CK5. Estrogens, androgens, or glucocorticoids have no effect on CK5. Thus in luminal ER+PR+ cells, P acting through PRs are absolutely required for CK5 induction. However, the newly activated CK5+ cell subpopulation is PR-. To explain this, PR+ and PR\#8722; cells with different fluorescent tags were treated with P in cocultures. CK5 was induced only in the PR+ cells. This indicates that CK5 is activated in the same cells that contain PR; there is no paracrine signal. PRs must be subsequently extinguished in these cells. Cycloheximide blocks CK5 induction by P indicating an indirect PR transcriptional effect. To assess the mechanism, the human CK5 promoter was linked to luciferase. In luminal PR+ breast cancer cells, P increases luciferase activity 20-fold. However ERK and Akt kinase pathway inhibitors suppress P-dependent activation of the CK5 promoter, suggesting that cell surface signaling mediates the P effects. To track living CK5+ cells, the CK5 promoter was linked to ZsGreen fluor, cloned into a lentivirus vector, and used to infect PR+ breast cancer cells. P for 24h induces ZsGreen fluorescence in a subpopulation of cells. Once induced, CK5 expression is irreversible; cells remain green fluorescent despite P withdrawal. Conclusions: Progestins induce a subset of ER+PR+CK5- luminal cells to acquire basal ER\#8722;PR\#8722;CK5+ stem cell-like properties. This phenotypic switch is permanent. We have proposed that in women with occult, undiagnosed breast cancer, P in HRT expands a cancer stem cell subpopulation. This deleterious effect of P might be prevented by kinase inhibitors.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 3069.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #3069: Progestin-dependent conversion of ER+PR+ CK5- luminal to ER\#8722;PR\#8722;CK5+ basal-like breast cancer stem cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #3069: Progestin-dependent conversion of ER+PR+ CK5- luminal to ER\#8722;PR\#8722;CK5+ basal-like breast cancer stem cells
James Haughian, Carol Sartorius and Kathryn Horwitz
Cancer Res May 1 2009 (69) (9 Supplement) 3069;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #3069: Progestin-dependent conversion of ER+PR+ CK5- luminal to ER\#8722;PR\#8722;CK5+ basal-like breast cancer stem cells
James Haughian, Carol Sartorius and Kathryn Horwitz
Cancer Res May 1 2009 (69) (9 Supplement) 3069;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Tumor Biology

  • Abstract SY34-04: Do we need to know what pO2 hypoxia is
  • Abstract SY28-04: Rational incorporation of novel agents into multimodality treatment of glioma and neuroblastoma
  • Abstract SY28-02: Connections in the BRCA1-BRCA2 pathway of homologous recombination: Implications for breast cancer development and treatment
Show more 3

Breast Cancer Stem Cells -- Poster Presentations - Proffered Abstracts

  • Abstract #3073: Nodal promotes metastatic phenotypes in breast cancer cells.
  • Abstract #3076: CD133, a unique stem cell surface marker in inflammatory breast cancer, functions both autocrinely as well as paracrinely in tumor cell survival
  • Abstract #3070: Reduced PIAS3 levels in T47D breast cancer cells promotes epithelial-mesenchymal transition and generates stem-like cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement